Economy
Swiss group agrees $390 million deal for medicines business with operations in North Africa
Swiss group DKSH has agreed to acquire NewBridge Pharmaceuticals in a transaction valued at $390 million, expanding its healthcare business into the Middle East and North Africa through a company with offices in Egypt, Algeria and Morocco . DKSH has agreed to acquire NewBridge Pharmaceuticals at a $390 million…
Business Insider AfricaBy Ayodeji Adegboyega
Share
Read the full story
Africa Business Review aggregates and summarises reporting from trusted publishers. The full article is published by Business Insider Africa.
Read at Business Insider Africa →Original headline: “Swiss group agrees $390 million deal for medicines business with operations in North Africa”
- Local Markets